For more than a half-century, WCGS has focused on preparing its students for careers in the biomedical sciences. The Graduate School faculty today numbers more than 250, and more than 1,000 students have earned Cornell University PhDs from the school.
The Tri-I PhD Program in Computational Biology and Medicine (CBM) was established in 2003 to provide a unique training opportunity that takes advantage of the exceptional educational and research resources of Cornell University in Ithaca, its Medical College in NYC (Weill Cornell Medical College), and Memorial Sloan Kettering Cancer Center. It is our belief that the development of such a cadre of computational biologists, trained in the laboratories of exceptional program faculty from all three campuses, will foster discovery in frontiers of basic biological and biomedical sciences.
The Tri-Institutional PhD Program in Chemical Biology was established in 2001 as one of the first graduate programs in the world to focus on research and training at the interface of chemistry and biology. The program is a collaborative offering of three premier New York City institutions, Weill Cornell Medical College, The Rockefeller University, and the Memorial Sloan Kettering Cancer Center. Located adjacent to one another in the heart of Manhattan’s Upper East Side, these three institutions combine to create a unique university environment and provide unparalleled scientific opportunities to the next generation of leaders in chemical biology.
Sudden cardiac death, primarily caused by ventricular arrhythmias, is a major public health problem – it is one of the leading causes of mortality, resulting in more than 350,000 annual deaths in the United States alone. Our group’s efforts are focused on improving our understanding of, and therapies for, cardiac arrhythmias. We primarily investigate biophysical mechanisms of electrophysiological instabilities and…
Our current research includes the structural biological studies to understand the mechanisms by which G-protein-coupled receptors activate G-proteins, and translational cancer biology. We are developing small-molecule compounds to block tumor cell migration, invasion and metastasis, as well as to reinvigorate anti-tumor immune response. We also investigate the physiological functions of G-proteins in blood vessel formation and bone homeostasis.